BiotechTube
Home/Aquilus Pharmaceuticals/Roy Sucholeiki, M.D.
RS

Roy Sucholeiki, M.D.

CMO & Vice President, Clinical Development

Aquilus Pharmaceuticals

Therapeutic Areas

Amyotrophic Lateral Sclerosis (ALS)Neurodegenerative Diseases

Aquilus Pharmaceuticals Pipeline

DrugIndicationPhase
AQU-118Amyotrophic Lateral Sclerosis (ALS)Phase 1

Leadership Team at Aquilus Pharmaceuticals

IS
Irving Sucholeiki, Ph.D.
President & Chief Executive Officer
DJ
Darrell J. Nix, Ph.D.
Vice President, R&D
View full Aquilus Pharmaceuticals profile